AJ12--Intent to Sole Source Novogene Inc. RNA Sequencing for VA Palo Alto Health Care System
Veterans Affairs · 261-NETWORK CONTRACT OFFICE 21 (36C261)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C26126Q1196 in this department, oldest first.
- Aug 26, 2026 · this noticeSpecial Notice
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
NOTICE OF INTENT TO SOLE SOURCE Department of Veterans Affairs VA Palo Alto Health Care System (VAPAHCS) Acquisition ID#: 36C261 26 AP 4343 The Department of Veterans Affairs, VA Palo Alto Health Care System (VAPAHCS), intends to award a Firm Fixed Price sole source contract to Novogene Corporation Inc. for single cell 3 RNA sequencing (scRNA seq) on fresh human cell samples, including full library preparation, sequencing, quality control, and downstream bioinformatics analysis. Authority This acquisition will be conducted under FAR 13.106 1(b)(1), soliciting from a single source when the cont… (show all)
racting officer determines that only one source is reasonably available. Description of Requirement VAPAHCS Research Service requires highly specialized 10x Genomics single cell RNA sequencing, including: Local same day pickup and immediate processing of fresh human samples to preserve RNA integrity Sample QC 10x Genomics library preparation Sequencing on the Ultima UG100 platform targeting 400 million raw reads per sample Full bioinformatics pipeline: demultiplexing, alignment, cell calling, clustering, HVG identification, marker gene detection, enrichment analysis Secure data return via SFTP All work performed at contractor s Sacramento, CA laboratory This work supports ongoing transcriptional level disease biology research requiring advanced single cell resolution. Estimated value: $18,171.00 (Firm Fixed Price) Period of Performance One (1) year from date of award, consistent with the supporting justification package. Not a Request for Quotes This notice is not a request for competitive quotes. However, interested parties may submit capability statements demonstrating they can meet every mandatory technical requirement. Send information to Rachael.Becker@va.gov. Contractors who do not provide the ability to perform the requirements identified below will not be considered responsive. The Government will use responses solely to determine if a competitive opportunity exists. Response Requirements Respondents must demonstrate: Ability to process fresh human samples same day, locally, without degradation Access to the Ultima UG100 platform Full 10x single cell workflow capability Full bioinformatics workflow Ability to meet the turnaround time and sample handling constraints Proof of relevant authorization and technical capability Only responses demonstrating complete equivalence will be considered.
Who won similar work
11 award notices on SAM.gov in the last 24 months. Match: Same agency (Veterans Affairs), same NAICS 541715.
| Winner | Awards | Value | Last |
|---|---|---|---|
| METABOLON, INC. | 2 | $2.1M | Apr 2, 2026 |
| UNIVERSITY OF UTAH SALT LAKE CITY 84112 | 1 | $11.2M | Jul 28, 2025 |
| KNOWTEX INC | 1 | $5.5M | Jul 22, 2025 |
| Abridge AI Inc | 1 | $5.4M | Jun 23, 2025 |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE SAN FRANCISCO 94103 | 1 | $1.4M | Feb 17, 2026 |
| THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 1 | $531K | May 6, 2025 |
| STUMPWORX LLC | 1 | $450K | Nov 5, 2024 |
| UNIVERSITY OF UTAH Salt Lake City UT 84112 USA | 1 | $323K | Jul 10, 2025 |
| UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO SAN ANTONIO 78229 | 1 | $275K | Sep 22, 2025 |
| AZENTA US INC | 1 | $140K | Jun 26, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.
- Jun 26, 2026AZENTA US INC$140KAJ12--RNA Sequencing
- Apr 2, 2026METABOLON, INC.$636KAN41--Metabolon Research Service
- Feb 17, 2026REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE SAN FRANCISCO 94103$1.4MAN42--WRIISC Veterans Control Group Repository
- Sep 24, 2025METABOLON, INC.$1.5MAN41--Metabolon Analyses Services Award Notice for Task Order
- Sep 22, 2025UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO SAN ANTONIO 78229$275KQ301--New- UTHSA CORE LAB
- Jul 28, 2025UNIVERSITY OF UTAH SALT LAKE CITY 84112$11.2MAJ11--Research Services
- Jul 22, 2025KNOWTEX INC$5.5MAward Notice: Ambient Scribe Sole Source - Knowtex
- Jul 10, 2025UNIVERSITY OF UTAH Salt Lake City UT 84112 USA$323KHealth Sciences Center CORES
- Jun 23, 2025Abridge AI Inc$5.4MAmbient Scribe Sole Source -Abridge
- May 6, 2025THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.$531KAN42--Henry M. Jackson Foundation for the Advancement of Military Medicine
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (2 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.